Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100

Medtronic PLC (MDT) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Medtronic PLC (MDT) trades at a P/B ratio of 2.4×. Over the past ten years it has ranged from 1.5× (July 2015) to 3.9× (January 2015); the current reading is higher than 58% of that period. That is in line with the Medical Devices industry median of 2.3× and in line with the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 2.1× (8.21%)
FY2025 2.3× 6.87%
FY2024 2.1× (9.47%)
FY2023 2.3× (11.12%)
FY2022 2.6× (23.04%)
FY2021 3.4× 32.62%
FY2020 2.6× 8.05%
FY2019 2.4× 11.33%
FY2018 2.1× (6.76%)
FY2017 2.3× 6.79%

Quarterly newest first

Period P/B ratio Change
Jul 2026 2.1× 3.68%
Apr 2026 2.1× (22.59%)
Jan 2026 2.7× 12.51%
Oct 2025 2.4× (0.95%)
43 more quarters

Against its own ten years

Low 1.5× High 3.9×
Ten-year median 2.3×
Current reading's percentile 57

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on MDT